Larimar Therapeutics Inc.
Clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
84 employees · est. 2016 · United States
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics for rare diseases
4 employees · est. 2019 · Nyon, Switzerland
Larimar Therapeutics Inc. is the older company (2016 vs 2019); Larimar Therapeutics Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Larimar Therapeutics Inc. | Nuvamid |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2019 |
| Headquarters | ||
| Headquarters | United States | Nyon, Switzerland |
| Employees | ||
| Employees | 84 larger | 4 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Health Care, Manufacturing, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Not tracked yet |
| Total Funding | ||
| Total Funding | $552.68M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 11 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Research and development of nucleotide-based therapies, Clinical stage trials for rare blood diseases, Collaboration with academic and research institutions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with rare blood diseases, Healthcare providers specializing in rare diseases, Pharmaceutical and biotech partners |
| Taxonomy | ||
| Taxonomy | Rare Diseases, Clinical-stage, Treatments, CTI-1601, Phase 1 Clinical Program, Friedreich’s Ataxia, Genetic Disease, Intracellular Delivery Platform, Fusion Proteins, Bioactive Compounds | Clinical Stage Biotech, Nucleotide Therapeutics, Rare Diseases, Endogenous Molecules, Breakthrough Therapeutics, Rare Blood Diseases, Blood Cell Disorders, NUV01, Phase 2 Clinical Trials, NAD Metabolism, NAD Metabolism Modulators, Preclinical Data, Immune Disorders, Research Collaborations, Biopharmaceutical Development |
| Website | ||
| Website | larimartx.com | nuvamid.com |
About Larimar Therapeutics Inc.
Larimar Therapeutics Inc. is a clinical-stage biotechnology company founded in 2005. It is focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently undergoing evaluation in a Phase 1 clinical program as a potential treatment for Friedreich’s ata...
About Nuvamid
Nuvamid, founded in 2019 and headquartered in Switzerland, is a clinical stage biotech with a focus on the research and utilization of nucleotides as therapeutics for rare diseases. Known for their slogan, "A clinical stage biotech focused on the research and use of nucleotides, as therapeutics for...
We will tell you when either one moves
BounceWatch watches Larimar Therapeutics Inc. and Nuvamid for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Larimar Therapeutics I... and Nuvamid — by email.
Frequently Asked Questions
Compare Larimar Therapeutics Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Larimar Therapeutics Inc. on 9 Jun 2026, and Nuvamid on 4 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.